🇺🇸 FDA
Pipeline program

CT-996

CT-996-201

Phase 1 small_molecule completed

Quick answer

CT-996 for Type 2 Diabetes is a Phase 1 program (small_molecule) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Type 2 Diabetes
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials